Cargando…

Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis

BACKGROUND: Pathology of gray matter is associated with development of physical and cognitive disability in patients with multiple sclerosis. In particular, glutamatergic dysregulation in the cortex-basal ganglia-thalamus (CxBGTh) circuit could be associated with decline in these behaviors. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Modica, Claire M., Schweser, Ferdinand, Sudyn, Michelle L., Bertolino, Nicola, Preda, Marilena, Polak, Paul, Siebert, Danielle M., Krawiecki, Jacqueline C., Sveinsson, Michele, Hagemeier, Jesper, Dwyer, Michael G., Pol, Suyog, Zivadinov, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552032/ https://www.ncbi.nlm.nih.gov/pubmed/28796815 http://dx.doi.org/10.1371/journal.pone.0182729

Ejemplares similares

Effect of Siponimod on Brain and Spinal Cord Imaging Markers of Neurodegeneration in the Theiler’s Murine Encephalomyelitis Virus Model of Demyelination
por: Pol, Suyog, et al.
Publicado: (2023)

Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals
por: Magnano, Christopher, et al.
Publicado: (2016)

Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients
por: Beggs, Clive B., et al.
Publicado: (2016)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS
por: Zivadinov, Robert, et al.
Publicado: (2020)

Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI
por: Schweser, Ferdinand, et al.
Publicado: (2020)

Glutamatergic neurons in paraventricular nucleus of the thalamus regulate the recovery from isoflurane anesthesia
por: Bu, Xiaoli, et al.
Publicado: (2022)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Transplantation of glutamatergic neuronal precursor cells in the paraventricular thalamus and claustrum facilitates awakening with recovery of consciousness
por: Zhao, Tong, et al.
Publicado: (2023)

Pathogenesis of Theiler's Murine Encephalomyelitis Virus
por: Yamada, Masahito, et al.
Publicado: (1991)

Immune mechanisms of Theiler's virus-induced demyelination
por: Kim, Byung Suk, et al.
Publicado: (1999)

Role of T cells in resistance to Theiler's virus infection()
por: Rodriguez, Moses, et al.
Publicado: (1991)

Endocannabinoid signaling regulates post-operative delirium through glutamatergic mediodorsal thalamus-prelimbic prefrontal cortical projection
por: Liu, Yang, et al.
Publicado: (2022)

A paraventricular thalamus to insular cortex glutamatergic projection gates “emotional” stress-induced binge eating in females
por: G. Anversa, Roberta, et al.
Publicado: (2023)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide
por: Elrefaey, Ahmed, et al.
Publicado: (2023)

Characterization of Ribosomal Frameshifting in Theiler's Murine Encephalomyelitis Virus
por: Finch, Leanne K., et al.
Publicado: (2015)

MLKL regulates Cx43 ubiquitinational degradation and mediates neuronal necroptosis in ipsilateral thalamus after focal cortical infarction
por: Tang, Yanyan, et al.
Publicado: (2023)

Longitudinal Magnetic Resonance Imaging of Cerebral Microbleeds in Multiple Sclerosis Patients
por: Subramanian, Karthikeyan, et al.
Publicado: (2020)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2014)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023)

Neuropathy in multiple sclerosis patients treated with teriflunomide
por: Kilic, Ahmet Kasim, et al.
Publicado: (2023)

The Role of Myelin in Theiler's Virus Persistence in the Central Nervous System
por: Roussarie, Jean-Pierre, et al.
Publicado: (2007)

A TRANSMISSIBLE AGENT (THEILER'S VIRUS) IN THE INTESTINES OF NORMAL MICE
por: Olitsky, Peter K.
Publicado: (1940)

SUSCEPTIBILITY OF MICE FREE OF THEILER'S VIRUS (TO STRAIN) TO INFECTION WITH TO VIRUS
por: Feltz, Elmer T., et al.
Publicado: (1953)

Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy
por: Pavelko, Kevin D., et al.
Publicado: (2011)

TDP-43 proteinopathy in Theiler’s murine encephalomyelitis virus infection
por: Masaki, Katsuhisa, et al.
Publicado: (2019)

Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update
por: Gerhauser, Ingo, et al.
Publicado: (2019)

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
por: Freedman, Mark S, et al.
Publicado: (2017)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

Teriflunomide treatment reduces B cells in patients with MS
por: Gandoglia, Ilaria, et al.
Publicado: (2017)

Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity
por: Ambrosius, Björn, et al.
Publicado: (2017)

COVID-19 in teriflunomide-treated patients with multiple sclerosis
por: Maghzi, Amir Hadi, et al.
Publicado: (2020)

Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_24b27gjausjf4in19l76gfec9r